Fungal Infection Diagnosis Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Fungal Infection Diagnosis market size was valued at USD 19 million in 2022 and is forecast to a readjusted size of USD 30 million by 2029 with a CAGR of 7.0% during review period.

Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida.  Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients. At present, most hospitals are carrying out non-invasive laboratory diagnosis techniques such as G test and GM test.

ASSOCIATES OF CAPE COD, BioRad, IMMY and other leading products occupy a leading position in the international market, with a total market share OF about 80% in the global market. Among them, Jinshanchuan, Danna Biological and Zhanjiang A & C Biological are domestic production enterprises in China, accounting for more than 90% in 2019. Among the two types of products, the galactomannan experiment accounts for the largest proportion, and in 2019, it accounts for about 60% of the market. The downstream application markets for the diagnosis of fungal infections are mainly hospitals, laboratories and others. Among them, hospitals accounted for the largest proportion.

This report is a detailed and comprehensive analysis for global Fungal Infection Diagnosis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Fungal Infection Diagnosis market size and forecasts, in consumption value ($ Million), 2018-2029
Global Fungal Infection Diagnosis market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Fungal Infection Diagnosis market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Fungal Infection Diagnosis market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Fungal Infection Diagnosis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Fungal Infection Diagnosis market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   ASSOCIATES OF CAPE COD
   BioRad
   IMMY
   Beijing Jinshanchuan
   Danna Biological
   Zhanjiang A & C Biological Ltd.

   Galactomannan Test
   (1 to 3)-β-D-glucan Experiment

   Hospital
   Laboratory
   Others

   North America (United States, Canada, and Mexico)
   Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
   South America (Brazil, Argentina and Rest of South America)
   Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

What are the strengths of the fungal infection diagnosis market in 2025?

The fungal infection diagnosis market in 2025 benefits from increased awareness of fungal diseases, a growing global patient population, and advancements in diagnostic technologies such as PCR-based tests, next-gen sequencing, and biomarkers. These innovations are enabling faster, more accurate diagnosis, improving treatment outcomes and reducing healthcare costs.

How about the weaknesses of this market?

Despite the progress, there are challenges such as the high cost of advanced diagnostic tools, limited access to specialized testing in low-resource settings, and a lack of standardized diagnostic protocols across regions. These barriers may hinder market expansion in certain areas, especially in developing countries.

What opportunities lie ahead for the fungal infection diagnosis market?

With the rising incidence of fungal infections, especially in immunocompromised populations, there is a growing need for better diagnostic solutions. The expansion of personalized medicine and molecular diagnostics offers new opportunities. Additionally, the rise in fungal infections due to climate change could further drive demand for innovative diagnostic methods.

What are the potential threats to this market?

The market could face threats from regulatory hurdles, especially as diagnostic tests undergo rigorous approval processes. The emergence of alternative treatments, such as new antifungal drugs, may also reduce the demand for diagnostic tools. Furthermore, competition from other diagnostic sectors, like bacterial or viral testing, could shift healthcare investments away from fungal diagnostics.

What political factors could impact the fungal infection diagnosis market in 2025?

Government regulations and healthcare policies, especially around diagnostic standards and reimbursement, will play a significant role. If countries implement stricter rules for diagnostic tools, it could slow the introduction of new technologies. Conversely, government funding for healthcare infrastructure could promote the adoption of advanced diagnostic techniques.

How do economic factors influence the fungal infection diagnosis market?

Economic stability impacts healthcare budgets, which in turn affects the investment in diagnostic technologies. In low-income countries, economic constraints might limit access to advanced fungal infection diagnostics. However, rising healthcare expenditure in developed nations may facilitate the growth of this market, allowing for more widespread adoption of diagnostic innovations.

What social factors are relevant to the fungal infection diagnosis market?

Increasing awareness about fungal infections, especially among vulnerable populations such as immunocompromised individuals, is encouraging early diagnosis. Public health campaigns focusing on infection prevention and the growing interest in wellness and health management contribute positively to market growth. However, cultural differences in health practices could delay adoption in some regions.

How do technological factors affect this market?

Advancements in molecular diagnostics, artificial intelligence, and machine learning for accurate detection of fungal infections are significantly shaping the market. Emerging technologies like PCR, sequencing, and biosensors are making diagnosis faster and more reliable. However, there may be concerns about the cost of such sophisticated tools, limiting their widespread use in resource-poor settings.

What environmental factors could impact the fungal infection diagnosis market?

Climate change has contributed to the increased prevalence of fungal infections, especially in regions with fluctuating weather patterns, which could drive demand for better diagnostic tools. Additionally, increased awareness of environmental factors like mold in indoor spaces may fuel diagnostic innovation. However, concerns about the environmental impact of manufacturing diagnostic tools could challenge sustainable growth.

What legal factors are involved in the fungal infection diagnosis market?

The market is subject to stringent regulatory frameworks regarding the approval of diagnostic devices and methods. Intellectual property rights, especially patents on diagnostic technologies, could affect the accessibility and pricing of tools. Additionally, legal challenges related to data privacy, particularly in the use of genomic and health data for diagnostics, may pose a hurdle for market players.

Who are the suppliers in the fungal infection diagnosis market in 2025?

Suppliers in this market include diagnostic equipment manufacturers, biotechnology companies producing diagnostic kits, and providers of molecular testing reagents. Additionally, suppliers of lab equipment, software for data analysis, and IT infrastructure for integrating diagnostic tools also play a critical role in the supply chain.

What inputs are needed for fungal infection diagnosis?

Inputs for fungal infection diagnosis include diagnostic reagents, test kits, molecular sequencing technology, PCR-based platforms, and biomarkers. Furthermore, trained medical professionals and laboratory infrastructure are crucial for accurate test execution and result interpretation.

Who are the primary process owners in the fungal infection diagnosis market?

Process owners include diagnostic laboratories, hospitals, healthcare providers, and medical research institutions. These entities manage the diagnostic process, from test execution to interpretation and reporting of results. Additionally, healthcare policymakers and regulatory agencies also play a significant role in overseeing the diagnostic process's standardization and quality control.

What outputs are produced in the fungal infection diagnosis market?

The main outputs include accurate and timely diagnosis of fungal infections, reports that guide clinicians in choosing the appropriate treatment, and data that help in tracking and managing the spread of fungal diseases. Advanced diagnostic technologies also produce research data for ongoing medical studies and product development.

Who are the customers of the fungal infection diagnosis market?

Customers include healthcare providers such as hospitals, clinics, and diagnostic centers, as well as pharmaceutical companies involved in developing antifungal treatments. Additionally, the end-users are patients, particularly those in vulnerable populations like immunocompromised individuals, as well as public health organizations monitoring fungal infections.

What is the threat of new entrants in the fungal infection diagnosis market?

The threat of new entrants is moderate. While there is a growing demand for diagnostic solutions, the high costs associated with developing advanced diagnostic technologies, regulatory hurdles, and the need for specialized expertise create significant barriers to entry. However, innovations in AI and cheaper diagnostic platforms could lower some of these barriers over time.

How intense is the rivalry among existing competitors in the market?

Rivalry among existing competitors is high. Established companies in diagnostics, biotech, and healthcare are constantly improving their technologies and expanding their product lines. Additionally, the market is also seeing collaborations, acquisitions, and the entrance of new tech-driven companies, which intensifies competition further, especially in terms of product innovation and pricing.

What is the bargaining power of suppliers in the fungal infection diagnosis market?

The bargaining power of suppliers is moderate. Key suppliers of diagnostic reagents, advanced testing equipment, and IT infrastructure hold a degree of power due to the specialized nature of their products. However, the increasing number of suppliers in the market, particularly as technologies evolve, provides buyers with options, reducing supplier power to some extent.

How strong is the bargaining power of buyers in the fungal infection diagnosis market?

The bargaining power of buyers is moderate to high. Hospitals, clinics, and large diagnostic laboratories have significant negotiating power due to their purchasing volumes. However, the specialized and highly accurate nature of advanced fungal infection diagnostic tools means that buyers may have fewer alternatives for specific needs, which somewhat reduces their power.

What is the threat of substitute products or services in the fungal infection diagnosis market?

The threat of substitutes is low to moderate. While other diagnostic methods, such as imaging or clinical symptom-based diagnosis, are available, they are often less accurate or slower compared to molecular diagnostics and PCR-based tests. However, the ongoing development of faster, cheaper, and more accessible diagnostic methods could pose a potential future substitute threat.

What raw materials and components are essential for the fungal infection diagnosis market?

The key raw materials and components include diagnostic reagents, molecular testing kits, DNA/RNA extraction agents, and PCR platforms. Additionally, specialized lab equipment, software for data analysis, and advanced biosensors play an essential role in the supply chain for fungal infection diagnostics.

Who are the key suppliers in the upstream value chain?

Key suppliers include biotechnology companies that produce reagents and diagnostic kits, manufacturers of testing platforms like PCR machines and sequencers, and companies that provide software and IT infrastructure for data management and analytics. Suppliers of raw materials for the production of testing equipment and diagnostic consumables are also crucial in the upstream chain.

How do technological advancements impact the upstream supply chain?

Technological advancements significantly influence the upstream supply chain by driving demand for more sophisticated diagnostic components, such as high-precision sensors and faster sequencing technologies. These innovations lead to the development of more accurate, reliable, and quicker diagnostic tests, which require high-quality inputs and advanced manufacturing processes from suppliers.

What are the potential challenges in the upstream supply chain?

Challenges in the upstream supply chain include fluctuations in the availability and cost of raw materials, particularly for specialized diagnostic reagents and equipment. Additionally, suppliers face regulatory hurdles in producing and distributing diagnostic components, and the complexity of developing cutting-edge technologies can lead to delays or higher production costs.

How do regulatory factors affect the upstream supply chain?

Regulatory factors play a significant role in the upstream supply chain, as diagnostic kits and reagents must adhere to stringent safety and efficacy standards set by health authorities like the FDA and EMA. Compliance with these regulations can increase production time and costs, while non-compliance may result in market access issues or product recalls.

What role do manufacturers play in the midstream of the fungal infection diagnosis market?

Manufacturers in the midstream segment are responsible for assembling, packaging, and distributing diagnostic tools and reagents. They ensure that these products meet quality standards and are ready for use in clinical settings. Manufacturers also play a critical role in innovating new diagnostic platforms and expanding the market reach of existing products.

How do distribution channels impact the midstream segment?

Distribution channels are crucial in ensuring that diagnostic tools reach healthcare providers, laboratories, and hospitals. These channels include direct sales, partnerships with healthcare institutions, and distribution via third-party logistics. Efficient distribution networks can drive market growth by ensuring timely availability of diagnostic products, particularly in underserved regions.

What are the main challenges in the midstream segment?

Key challenges in the midstream segment include logistical issues like supply chain disruptions, inventory management, and delays in product delivery. There is also pressure to meet the rising demand for diagnostic products, especially in global markets with varying regulatory and healthcare infrastructure standards, which can complicate distribution strategies.

How does pricing affect the midstream of the fungal infection diagnosis market?

Pricing is a critical factor in the midstream segment as manufacturers, distributors, and healthcare providers work to balance the cost of diagnostic tools with their accessibility and profitability. High pricing may limit the adoption of advanced diagnostic methods, particularly in low-resource settings, whereas competitive pricing strategies can drive widespread use and market expansion.

What is the role of partnerships in the midstream value chain?

Partnerships between manufacturers, distributors, and healthcare organizations are vital for expanding the reach and efficacy of diagnostic products. Collaborations often help overcome regulatory hurdles, enhance distribution capabilities, and enable joint research initiatives for the development of more advanced and affordable diagnostic solutions.

What role do healthcare providers play in the downstream segment of the fungal infection diagnosis market?

Healthcare providers, including hospitals, clinics, and diagnostic laboratories, are at the forefront of implementing fungal infection diagnostic tests. They use these tools to diagnose infections accurately, guide treatment decisions, and monitor patient outcomes. Their feedback also helps drive improvements in diagnostic technologies and services.

How does patient access to diagnostic services impact the downstream segment?

Patient access to diagnostic services is a critical factor in the downstream segment. Widespread availability of diagnostic tools in hospitals, clinics, and remote healthcare settings increases early detection and improves treatment outcomes. Access barriers such as cost, geographic location, and healthcare infrastructure disparities may limit market reach and overall effectiveness.

What challenges do healthcare providers face in the downstream market?

Healthcare providers face several challenges, including limited resources in low-income regions, rising demand for accurate and timely fungal infection diagnostics, and pressure to reduce diagnostic costs. Furthermore, the complexity of advanced diagnostic technologies may require specialized training, which can be a barrier in some areas, particularly in resource-constrained settings.

How does reimbursement policy affect the downstream segment?

Reimbursement policies significantly influence the adoption of diagnostic technologies. If insurance companies and government health schemes do not adequately cover the costs of fungal infection diagnostics, patients and healthcare providers may be reluctant to adopt newer, more expensive diagnostic methods. Clear reimbursement guidelines can drive broader use of advanced diagnostics and improve patient outcomes.

How do end-users (patients) impact the downstream market?

Patients directly influence the downstream market through their demand for quicker, more accurate diagnostic services. As awareness of fungal infections increases, patients are more likely to seek early diagnosis, which drives the demand for advanced diagnostic tests. Additionally, patient outcomes and satisfaction with diagnostic services can shape healthcare providers' decisions on which diagnostic tools to adopt.

Chapter 1, to describe Fungal Infection Diagnosis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Fungal Infection Diagnosis, with revenue, gross margin and global market share of Fungal Infection Diagnosis from 2018 to 2023.
Chapter 3, the Fungal Infection Diagnosis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Fungal Infection Diagnosis market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Fungal Infection Diagnosis.
Chapter 13, to describe Fungal Infection Diagnosis research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Fungal Infection Diagnosis
   1.2 Market Estimation Caveats and Base Year
   1.3 Classification of Fungal Infection Diagnosis by Type
       1.3.1 Overview: Global Fungal Infection Diagnosis Market Size by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Global Fungal Infection Diagnosis Consumption Value Market Share by Type in 2022
       1.3.3 Galactomannan Test
       1.3.4 (1 to 3)-β-D-glucan Experiment
   1.4 Global Fungal Infection Diagnosis Market by Application
       1.4.1 Overview: Global Fungal Infection Diagnosis Market Size by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Hospital
       1.4.3 Laboratory
       1.4.4 Others
   1.5 Global Fungal Infection Diagnosis Market Size & Forecast
   1.6 Global Fungal Infection Diagnosis Market Size and Forecast by Region
       1.6.1 Global Fungal Infection Diagnosis Market Size by Region: 2018 VS 2022 VS 2029
       1.6.2 Global Fungal Infection Diagnosis Market Size by Region, (2018-2029)
       1.6.3 North America Fungal Infection Diagnosis Market Size and Prospect (2018-2029)
       1.6.4 Europe Fungal Infection Diagnosis Market Size and Prospect (2018-2029)
       1.6.5 Asia-Pacific Fungal Infection Diagnosis Market Size and Prospect (2018-2029)
       1.6.6 South America Fungal Infection Diagnosis Market Size and Prospect (2018-2029)
       1.6.7 Middle East and Africa Fungal Infection Diagnosis Market Size and Prospect (2018-2029)

2 Company Profiles

   2.1 ASSOCIATES OF CAPE COD
       2.1.1 ASSOCIATES OF CAPE COD Details
       2.1.2 ASSOCIATES OF CAPE COD Major Business
       2.1.3 ASSOCIATES OF CAPE COD Fungal Infection Diagnosis Product and Solutions
       2.1.4 ASSOCIATES OF CAPE COD Fungal Infection Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 ASSOCIATES OF CAPE COD Recent Developments and Future Plans
   2.2 BioRad
       2.2.1 BioRad Details
       2.2.2 BioRad Major Business
       2.2.3 BioRad Fungal Infection Diagnosis Product and Solutions
       2.2.4 BioRad Fungal Infection Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 BioRad Recent Developments and Future Plans
   2.3 IMMY
       2.3.1 IMMY Details
       2.3.2 IMMY Major Business
       2.3.3 IMMY Fungal Infection Diagnosis Product and Solutions
       2.3.4 IMMY Fungal Infection Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 IMMY Recent Developments and Future Plans
   2.4 Beijing Jinshanchuan
       2.4.1 Beijing Jinshanchuan Details
       2.4.2 Beijing Jinshanchuan Major Business
       2.4.3 Beijing Jinshanchuan Fungal Infection Diagnosis Product and Solutions
       2.4.4 Beijing Jinshanchuan Fungal Infection Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Beijing Jinshanchuan Recent Developments and Future Plans
   2.5 Danna Biological
       2.5.1 Danna Biological Details
       2.5.2 Danna Biological Major Business
       2.5.3 Danna Biological Fungal Infection Diagnosis Product and Solutions
       2.5.4 Danna Biological Fungal Infection Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Danna Biological Recent Developments and Future Plans
   2.6 Zhanjiang A & C Biological Ltd.
       2.6.1 Zhanjiang A & C Biological Ltd. Details
       2.6.2 Zhanjiang A & C Biological Ltd. Major Business
       2.6.3 Zhanjiang A & C Biological Ltd. Fungal Infection Diagnosis Product and Solutions
       2.6.4 Zhanjiang A & C Biological Ltd. Fungal Infection Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Zhanjiang A & C Biological Ltd. Recent Developments and Future Plans

3 Market Competition, by Players

   3.1 Global Fungal Infection Diagnosis Revenue and Share by Players (2018-2023)
   3.2 Market Share Analysis (2022)
       3.2.1 Market Share of Fungal Infection Diagnosis by Company Revenue
       3.2.2 Top 3 Fungal Infection Diagnosis Players Market Share in 2022
       3.2.3 Top 6 Fungal Infection Diagnosis Players Market Share in 2022
   3.3 Fungal Infection Diagnosis Market: Overall Company Footprint Analysis
       3.3.1 Fungal Infection Diagnosis Market: Region Footprint
       3.3.2 Fungal Infection Diagnosis Market: Company Product Type Footprint
       3.3.3 Fungal Infection Diagnosis Market: Company Product Application Footprint
   3.4 New Market Entrants and Barriers to Market Entry
   3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

   4.1 Global Fungal Infection Diagnosis Consumption Value and Market Share by Type (2018-2023)
   4.2 Global Fungal Infection Diagnosis Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

   5.1 Global Fungal Infection Diagnosis Consumption Value Market Share by Application (2018-2023)
   5.2 Global Fungal Infection Diagnosis Market Forecast by Application (2024-2029)

6 North America

   6.1 North America Fungal Infection Diagnosis Consumption Value by Type (2018-2029)
   6.2 North America Fungal Infection Diagnosis Consumption Value by Application (2018-2029)
   6.3 North America Fungal Infection Diagnosis Market Size by Country
       6.3.1 North America Fungal Infection Diagnosis Consumption Value by Country (2018-2029)
       6.3.2 United States Fungal Infection Diagnosis Market Size and Forecast (2018-2029)
       6.3.3 Canada Fungal Infection Diagnosis Market Size and Forecast (2018-2029)
       6.3.4 Mexico Fungal Infection Diagnosis Market Size and Forecast (2018-2029)

7 Europe

   7.1 Europe Fungal Infection Diagnosis Consumption Value by Type (2018-2029)
   7.2 Europe Fungal Infection Diagnosis Consumption Value by Application (2018-2029)
   7.3 Europe Fungal Infection Diagnosis Market Size by Country
       7.3.1 Europe Fungal Infection Diagnosis Consumption Value by Country (2018-2029)
       7.3.2 Germany Fungal Infection Diagnosis Market Size and Forecast (2018-2029)
       7.3.3 France Fungal Infection Diagnosis Market Size and Forecast (2018-2029)
       7.3.4 United Kingdom Fungal Infection Diagnosis Market Size and Forecast (2018-2029)
       7.3.5 Russia Fungal Infection Diagnosis Market Size and Forecast (2018-2029)
       7.3.6 Italy Fungal Infection Diagnosis Market Size and Forecast (2018-2029)

8 Asia-Pacific

   8.1 Asia-Pacific Fungal Infection Diagnosis Consumption Value by Type (2018-2029)
   8.2 Asia-Pacific Fungal Infection Diagnosis Consumption Value by Application (2018-2029)
   8.3 Asia-Pacific Fungal Infection Diagnosis Market Size by Region
       8.3.1 Asia-Pacific Fungal Infection Diagnosis Consumption Value by Region (2018-2029)
       8.3.2 China Fungal Infection Diagnosis Market Size and Forecast (2018-2029)
       8.3.3 Japan Fungal Infection Diagnosis Market Size and Forecast (2018-2029)
       8.3.4 South Korea Fungal Infection Diagnosis Market Size and Forecast (2018-2029)
       8.3.5 India Fungal Infection Diagnosis Market Size and Forecast (2018-2029)
       8.3.6 Southeast Asia Fungal Infection Diagnosis Market Size and Forecast (2018-2029)
       8.3.7 Australia Fungal Infection Diagnosis Market Size and Forecast (2018-2029)

9 South America

   9.1 South America Fungal Infection Diagnosis Consumption Value by Type (2018-2029)
   9.2 South America Fungal Infection Diagnosis Consumption Value by Application (2018-2029)
   9.3 South America Fungal Infection Diagnosis Market Size by Country
       9.3.1 South America Fungal Infection Diagnosis Consumption Value by Country (2018-2029)
       9.3.2 Brazil Fungal Infection Diagnosis Market Size and Forecast (2018-2029)
       9.3.3 Argentina Fungal Infection Diagnosis Market Size and Forecast (2018-2029)

10 Middle East & Africa

   10.1 Middle East & Africa Fungal Infection Diagnosis Consumption Value by Type (2018-2029)
   10.2 Middle East & Africa Fungal Infection Diagnosis Consumption Value by Application (2018-2029)
   10.3 Middle East & Africa Fungal Infection Diagnosis Market Size by Country
       10.3.1 Middle East & Africa Fungal Infection Diagnosis Consumption Value by Country (2018-2029)
       10.3.2 Turkey Fungal Infection Diagnosis Market Size and Forecast (2018-2029)
       10.3.3 Saudi Arabia Fungal Infection Diagnosis Market Size and Forecast (2018-2029)
       10.3.4 UAE Fungal Infection Diagnosis Market Size and Forecast (2018-2029)

11 Market Dynamics

   11.1 Fungal Infection Diagnosis Market Drivers
   11.2 Fungal Infection Diagnosis Market Restraints
   11.3 Fungal Infection Diagnosis Trends Analysis
   11.4 Porters Five Forces Analysis
       11.4.1 Threat of New Entrants
       11.4.2 Bargaining Power of Suppliers
       11.4.3 Bargaining Power of Buyers
       11.4.4 Threat of Substitutes
       11.4.5 Competitive Rivalry
   11.5 Influence of COVID-19 and Russia-Ukraine War
       11.5.1 Influence of COVID-19
       11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

   12.1 Fungal Infection Diagnosis Industry Chain
   12.2 Fungal Infection Diagnosis Upstream Analysis
   12.3 Fungal Infection Diagnosis Midstream Analysis
   12.4 Fungal Infection Diagnosis Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

   14.1 Methodology
   14.2 Research Process and Data Source
   14.3 Disclaimer

List of Tables

   Table 1. Global Fungal Infection Diagnosis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Fungal Infection Diagnosis Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Global Fungal Infection Diagnosis Consumption Value by Region (2018-2023) & (USD Million)
   Table 4. Global Fungal Infection Diagnosis Consumption Value by Region (2024-2029) & (USD Million)
   Table 5. ASSOCIATES OF CAPE COD Company Information, Head Office, and Major Competitors
   Table 6. ASSOCIATES OF CAPE COD Major Business
   Table 7. ASSOCIATES OF CAPE COD Fungal Infection Diagnosis Product and Solutions
   Table 8. ASSOCIATES OF CAPE COD Fungal Infection Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 9. ASSOCIATES OF CAPE COD Recent Developments and Future Plans
   Table 10. BioRad Company Information, Head Office, and Major Competitors
   Table 11. BioRad Major Business
   Table 12. BioRad Fungal Infection Diagnosis Product and Solutions
   Table 13. BioRad Fungal Infection Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 14. BioRad Recent Developments and Future Plans
   Table 15. IMMY Company Information, Head Office, and Major Competitors
   Table 16. IMMY Major Business
   Table 17. IMMY Fungal Infection Diagnosis Product and Solutions
   Table 18. IMMY Fungal Infection Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 19. IMMY Recent Developments and Future Plans
   Table 20. Beijing Jinshanchuan Company Information, Head Office, and Major Competitors
   Table 21. Beijing Jinshanchuan Major Business
   Table 22. Beijing Jinshanchuan Fungal Infection Diagnosis Product and Solutions
   Table 23. Beijing Jinshanchuan Fungal Infection Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 24. Beijing Jinshanchuan Recent Developments and Future Plans
   Table 25. Danna Biological Company Information, Head Office, and Major Competitors
   Table 26. Danna Biological Major Business
   Table 27. Danna Biological Fungal Infection Diagnosis Product and Solutions
   Table 28. Danna Biological Fungal Infection Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 29. Danna Biological Recent Developments and Future Plans
   Table 30. Zhanjiang A & C Biological Ltd. Company Information, Head Office, and Major Competitors
   Table 31. Zhanjiang A & C Biological Ltd. Major Business
   Table 32. Zhanjiang A & C Biological Ltd. Fungal Infection Diagnosis Product and Solutions
   Table 33. Zhanjiang A & C Biological Ltd. Fungal Infection Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 34. Zhanjiang A & C Biological Ltd. Recent Developments and Future Plans
   Table 35. Global Fungal Infection Diagnosis Revenue (USD Million) by Players (2018-2023)
   Table 36. Global Fungal Infection Diagnosis Revenue Share by Players (2018-2023)
   Table 37. Breakdown of Fungal Infection Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3)
   Table 38. Market Position of Players in Fungal Infection Diagnosis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
   Table 39. Head Office of Key Fungal Infection Diagnosis Players
   Table 40. Fungal Infection Diagnosis Market: Company Product Type Footprint
   Table 41. Fungal Infection Diagnosis Market: Company Product Application Footprint
   Table 42. Fungal Infection Diagnosis New Market Entrants and Barriers to Market Entry
   Table 43. Fungal Infection Diagnosis Mergers, Acquisition, Agreements, and Collaborations
   Table 44. Global Fungal Infection Diagnosis Consumption Value (USD Million) by Type (2018-2023)
   Table 45. Global Fungal Infection Diagnosis Consumption Value Share by Type (2018-2023)
   Table 46. Global Fungal Infection Diagnosis Consumption Value Forecast by Type (2024-2029)
   Table 47. Global Fungal Infection Diagnosis Consumption Value by Application (2018-2023)
   Table 48. Global Fungal Infection Diagnosis Consumption Value Forecast by Application (2024-2029)
   Table 49. North America Fungal Infection Diagnosis Consumption Value by Type (2018-2023) & (USD Million)
   Table 50. North America Fungal Infection Diagnosis Consumption Value by Type (2024-2029) & (USD Million)
   Table 51. North America Fungal Infection Diagnosis Consumption Value by Application (2018-2023) & (USD Million)
   Table 52. North America Fungal Infection Diagnosis Consumption Value by Application (2024-2029) & (USD Million)
   Table 53. North America Fungal Infection Diagnosis Consumption Value by Country (2018-2023) & (USD Million)
   Table 54. North America Fungal Infection Diagnosis Consumption Value by Country (2024-2029) & (USD Million)
   Table 55. Europe Fungal Infection Diagnosis Consumption Value by Type (2018-2023) & (USD Million)
   Table 56. Europe Fungal Infection Diagnosis Consumption Value by Type (2024-2029) & (USD Million)
   Table 57. Europe Fungal Infection Diagnosis Consumption Value by Application (2018-2023) & (USD Million)
   Table 58. Europe Fungal Infection Diagnosis Consumption Value by Application (2024-2029) & (USD Million)
   Table 59. Europe Fungal Infection Diagnosis Consumption Value by Country (2018-2023) & (USD Million)
   Table 60. Europe Fungal Infection Diagnosis Consumption Value by Country (2024-2029) & (USD Million)
   Table 61. Asia-Pacific Fungal Infection Diagnosis Consumption Value by Type (2018-2023) & (USD Million)
   Table 62. Asia-Pacific Fungal Infection Diagnosis Consumption Value by Type (2024-2029) & (USD Million)
   Table 63. Asia-Pacific Fungal Infection Diagnosis Consumption Value by Application (2018-2023) & (USD Million)
   Table 64. Asia-Pacific Fungal Infection Diagnosis Consumption Value by Application (2024-2029) & (USD Million)
   Table 65. Asia-Pacific Fungal Infection Diagnosis Consumption Value by Region (2018-2023) & (USD Million)
   Table 66. Asia-Pacific Fungal Infection Diagnosis Consumption Value by Region (2024-2029) & (USD Million)
   Table 67. South America Fungal Infection Diagnosis Consumption Value by Type (2018-2023) & (USD Million)
   Table 68. South America Fungal Infection Diagnosis Consumption Value by Type (2024-2029) & (USD Million)
   Table 69. South America Fungal Infection Diagnosis Consumption Value by Application (2018-2023) & (USD Million)
   Table 70. South America Fungal Infection Diagnosis Consumption Value by Application (2024-2029) & (USD Million)
   Table 71. South America Fungal Infection Diagnosis Consumption Value by Country (2018-2023) & (USD Million)
   Table 72. South America Fungal Infection Diagnosis Consumption Value by Country (2024-2029) & (USD Million)
   Table 73. Middle East & Africa Fungal Infection Diagnosis Consumption Value by Type (2018-2023) & (USD Million)
   Table 74. Middle East & Africa Fungal Infection Diagnosis Consumption Value by Type (2024-2029) & (USD Million)
   Table 75. Middle East & Africa Fungal Infection Diagnosis Consumption Value by Application (2018-2023) & (USD Million)
   Table 76. Middle East & Africa Fungal Infection Diagnosis Consumption Value by Application (2024-2029) & (USD Million)
   Table 77. Middle East & Africa Fungal Infection Diagnosis Consumption Value by Country (2018-2023) & (USD Million)
   Table 78. Middle East & Africa Fungal Infection Diagnosis Consumption Value by Country (2024-2029) & (USD Million)
   Table 79. Fungal Infection Diagnosis Raw Material
   Table 80. Key Suppliers of Fungal Infection Diagnosis Raw Materials

List of Figures

   Figure 1. Fungal Infection Diagnosis Picture
   Figure 2. Global Fungal Infection Diagnosis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Fungal Infection Diagnosis Consumption Value Market Share by Type in 2022
   Figure 4. Galactomannan Test
   Figure 5. (1 to 3)-β-D-glucan Experiment
   Figure 6. Global Fungal Infection Diagnosis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 7. Fungal Infection Diagnosis Consumption Value Market Share by Application in 2022
   Figure 8. Hospital Picture
   Figure 9. Laboratory Picture
   Figure 10. Others Picture
   Figure 11. Global Fungal Infection Diagnosis Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 12. Global Fungal Infection Diagnosis Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 13. Global Market Fungal Infection Diagnosis Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
   Figure 14. Global Fungal Infection Diagnosis Consumption Value Market Share by Region (2018-2029)
   Figure 15. Global Fungal Infection Diagnosis Consumption Value Market Share by Region in 2022
   Figure 16. North America Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 17. Europe Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 18. Asia-Pacific Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 19. South America Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 20. Middle East and Africa Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 21. Global Fungal Infection Diagnosis Revenue Share by Players in 2022
   Figure 22. Fungal Infection Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
   Figure 23. Global Top 3 Players Fungal Infection Diagnosis Market Share in 2022
   Figure 24. Global Top 6 Players Fungal Infection Diagnosis Market Share in 2022
   Figure 25. Global Fungal Infection Diagnosis Consumption Value Share by Type (2018-2023)
   Figure 26. Global Fungal Infection Diagnosis Market Share Forecast by Type (2024-2029)
   Figure 27. Global Fungal Infection Diagnosis Consumption Value Share by Application (2018-2023)
   Figure 28. Global Fungal Infection Diagnosis Market Share Forecast by Application (2024-2029)
   Figure 29. North America Fungal Infection Diagnosis Consumption Value Market Share by Type (2018-2029)
   Figure 30. North America Fungal Infection Diagnosis Consumption Value Market Share by Application (2018-2029)
   Figure 31. North America Fungal Infection Diagnosis Consumption Value Market Share by Country (2018-2029)
   Figure 32. United States Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 33. Canada Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 34. Mexico Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 35. Europe Fungal Infection Diagnosis Consumption Value Market Share by Type (2018-2029)
   Figure 36. Europe Fungal Infection Diagnosis Consumption Value Market Share by Application (2018-2029)
   Figure 37. Europe Fungal Infection Diagnosis Consumption Value Market Share by Country (2018-2029)
   Figure 38. Germany Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 39. France Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 40. United Kingdom Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 41. Russia Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 42. Italy Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 43. Asia-Pacific Fungal Infection Diagnosis Consumption Value Market Share by Type (2018-2029)
   Figure 44. Asia-Pacific Fungal Infection Diagnosis Consumption Value Market Share by Application (2018-2029)
   Figure 45. Asia-Pacific Fungal Infection Diagnosis Consumption Value Market Share by Region (2018-2029)
   Figure 46. China Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 47. Japan Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 48. South Korea Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 49. India Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 50. Southeast Asia Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 51. Australia Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 52. South America Fungal Infection Diagnosis Consumption Value Market Share by Type (2018-2029)
   Figure 53. South America Fungal Infection Diagnosis Consumption Value Market Share by Application (2018-2029)
   Figure 54. South America Fungal Infection Diagnosis Consumption Value Market Share by Country (2018-2029)
   Figure 55. Brazil Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 56. Argentina Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 57. Middle East and Africa Fungal Infection Diagnosis Consumption Value Market Share by Type (2018-2029)
   Figure 58. Middle East and Africa Fungal Infection Diagnosis Consumption Value Market Share by Application (2018-2029)
   Figure 59. Middle East and Africa Fungal Infection Diagnosis Consumption Value Market Share by Country (2018-2029)
   Figure 60. Turkey Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 61. Saudi Arabia Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 62. UAE Fungal Infection Diagnosis Consumption Value (2018-2029) & (USD Million)
   Figure 63. Fungal Infection Diagnosis Market Drivers
   Figure 64. Fungal Infection Diagnosis Market Restraints
   Figure 65. Fungal Infection Diagnosis Market Trends
   Figure 66. Porters Five Forces Analysis
   Figure 67. Manufacturing Cost Structure Analysis of Fungal Infection Diagnosis in 2022
   Figure 68. Manufacturing Process Analysis of Fungal Infection Diagnosis
   Figure 69. Fungal Infection Diagnosis Industrial Chain
   Figure 70. Methodology
   Figure 71. Research Process and Data Source